ANALISIS RASIO PASAR UNTUK MENGUKUR PENGEMBALIAN INVESTASI PADA PT KALBE FARMA Tbk
| Main Author: | Rozak, Elvia |
|---|---|
| Format: | Thesis NonPeerReviewed Book |
| Bahasa: | eng |
| Terbitan: |
, 2014
|
| Subjects: | |
| Online Access: |
http://repository.fe.unj.ac.id/3252/1/Cover.pdf http://repository.fe.unj.ac.id/3252/2/Table_Of_Content.pdf http://repository.fe.unj.ac.id/3252/3/Chapter_1.pdf http://repository.fe.unj.ac.id/3252/4/Chapter_2.pdf http://repository.fe.unj.ac.id/3252/5/Chapter_3.pdf http://repository.fe.unj.ac.id/3252/6/Chapter_4.pdf http://repository.fe.unj.ac.id/3252/7/Bibliography.pdf http://repository.fe.unj.ac.id/3252/ |
Daftar Isi:
- ELVIA ROZAK. 2011. 8323118245. Analisis Rasio Pasar Untuk Mengukur Pengembalian Investasi PT Kalbe Farma Tbk. Program Studi DIII Akuntansi. Jurusan Akuntansi. Fakultas Ekonomi. Universitas Negeri Jakarta. This paper has a purpose to help the investors or prospective investors in assessing the performance management of a company at PT Kalbe Farma Tbk to then be taken into consideration in determining the feasibility of investing in the shares of the company. From the ratio of the market to determine the level up dividend payout ratio, book value ratio, the ratio of earnings per share, price earnings ratio, the ratio of capitalization rate, and the ratio of dividend income. The method use in this research is a analysis of the quantitative methods of data collection through secondary data from the annual financial statements PT Kalbe Farma Tbk with Pharmaceutical Industry Average (PT Kimia Farma Tbk, PT Pyridam Farma Tbk, PT Merck Tbk, PT Tempo Scan Pasific Tbk, dan PT Darya Varia Laboratoria Tbk) the period 2009-2012 as well as the study of literature. From the results it can be concluded that measuring return on investment compared PT Kalbe Farma Tbk with Pharmaceutical Industry Average. Analysis of the ratio of the market for 4 years to measure the return on investment that can be seen from the performance of PT Kalbe Farma Tbk and its management in it is still less than the maximum and needs improvement in terms of achieving the interest of its shareholders. Return on investment of PT Kalbe Farma Tbk broadly speaking, the period 2009-2012 is quite good, although there was no significant improvement but still maintain Kalbe investment rate of return remained positive on the position that the company can make a profit with their own capital capabilities that could benefit shareholders.